Beatrice Valenti
Research Subjects
Beatrice Valenti has a total of 45 co-authors. Here are the top co-authors by number of shared publications:
Aino Palva
1 shared publication- Alain J. van Gool
Translational Metabolic Laboratory, Department of Laboratory Medicine, Radboud University Medical Center
1 shared publication - Andreas Scherer
Institute for Molecular Medicine Finland (FIMM), University of Helsinki, Helsinki, Finland
1 shared publication - Anna Niehues
Institute for Biology and Biotechnology of Plants, University of Münster, Münster, Germany
1 shared publication - Anni I. Nieminen
Stem Cell and Metabolism Research Program, Faculty of Medicine, University of Helsinki, Helsinki, Finland
1 shared publication - Bhagwan Yadav
Institute for Molecular Medicine Finland (FIMM), Helsinki Institute of Life Science, University of Helsinki, Helsinki, Finland
1 shared publication
Latest Publications
- Open Access
- 1 April 2025
- Published by Springer Nature in Phenomics
- Vol. 5 (3) , 311-325
Multi-omics Quality Assessment in Personalized Medicine Through European Infrastructure for Translational Medicine (EATRIS): An Overview
Molecular characterization of a biological sample, e.g., with omics approaches, is fundamental for the development and implementation of personalized and precision medicine approaches. In this context, quality assessment is one of the most critical aspects. Accurate performance and interpretation of omics techniques is based on consensus, harmonization, and standardization of protocols, procedures, data analysis and reference values and materials. EATRIS, the European Infrastructure for Translational Medicine (www.EATRIS.eu), brings together resources and services to support researchers in developing their biomedical discoveries into novel translational tools and interventions for better health outcomes. Here we describe the efforts within the Horizon 2020 EATRIS-Plus project and activities of member facilities of EATRIS towards quality assessment of pre-clinical sample processing, clinical omics data generation, multi-omics data integration, and dissemination of the resources in a Multi-Omics Toolbox, which is the principal deliverable of the EATRIS-Plus project for the consolidation of EATRIS towards translational medicine.
- 1 April 2025
- Published by Springer Nature in Phenomics
- Vol. 5 (3) , 311-325
Open AccessMulti-omics Quality Assessment in Personalized Medicine Through European Infrastructure for Translational Medicine (EATRIS): An Overview
Molecular characterization of a biological sample, e.g., with omics approaches, is fundamental for the development and implementation of personalized and precision medicine approaches. In this context, quality assessment is one of the most critical aspects. Accurate performance and interpretation of omics techniques is based on consensus, harmonization, and standardization of protocols, procedures, data analysis and reference values and materials. EATRIS, the European Infrastructure for Translational Medicine (www.EATRIS.eu), brings together resources and services to support researchers in developing their biomedical discoveries into novel translational tools and interventions for better health outcomes. Here we describe the efforts within the Horizon 2020 EATRIS-Plus project and activities of member facilities of EATRIS towards quality assessment of pre-clinical sample processing, clinical omics data generation, multi-omics data integration, and dissemination of the resources in a Multi-Omics Toolbox, which is the principal deliverable of the EATRIS-Plus project for the consolidation of EATRIS towards translational medicine.